Case Summary:

A Postdoctoral Researcher holding a Ph.D. in Neuroscience and MD from Japan approached North America Immigration Law Group (NAILG) to file an effective petition on his behalf under the EB-2 NIW (National Interest Waiver) visa category. Before starting with a client-attorney agreement, we evaluated his provided credentials to determine his NIW’s success. After a complete review of his research on immunotherapeutic strategies for treating malignant brain tumors, we deduced that his case must be taken forward considering his research promotes the growth of cancer immunotherapy, which has become an integral part of cancer care today.

A few attributes, we listed in his petition packet are mentioned below:

• Publication Record: we recognized the 24 peer-reviewed journal articles (6 of them first-authored) and 1 book chapter he published in some of the most discerning, high-impact journals in his field of neuro-oncology.
• Citation Record: an impressive record of obtaining 370 citations in other peer-reviewed journal articles, further indicated the major significance of his work.
• Review Experience: he has completed at least 16 reviews to date.
• Funding: his study has received funding from the Japan Society for the Promotion of Science, the Japan Agency for Medical Research and Development, the V Foundation for Cancer Research, the Pacific Pediatric Neuro-Oncology Consortium Foundation, the Pediatric Brain Tumor Foundation, the Mithil Prasad Foundation, the Parker Institute for Cancer Immunotherapy, the National Institute of Neurological Disorders and Stroke and the National Institutes of Health.
• Importance of his work: his proposed endeavor is to continue applying bioinformatics, genomics, transcriptomics, and genome engineering techniques to the analysis and development of immunotherapeutic strategies like vaccines, cell therapies, virus therapies, and their combinations in order to improve the prognosis of malignant brain tumors.
• Broad implications for the United States: he has dedicated his career to this pursuit and in the process has improved his field’s understanding of malignant brain tumors while providing the American healthcare system with new vaccines and other strategies for managing them.

In addition to the above-mentioned details, we also incorporated the two recommendation letters that our client accommodated from the fellow experts in his field of expertise.

Thus, as the documentary evidence and corroborating testimony from experts in the field establish, he is a member of the professions holding an advanced degree. He proposes to continue his research on immunotherapeutic strategies for treating malignant brain tumors, which is clearly an endeavor with substantial merit and national importance. His education, experience, and expertise, record of publication and citation, and history of successful research in the field all indicate that our client is well positioned to advance the proposed endeavor.

We are delighted that our team was finally fortunate enough in persuading USCIS of the importance of our client’s research in the United States and thus he achieved his I-140 NIW (National Interest Waiver) case approval. We would sincerely like to thank him for choosing our law firm and congratulate him for getting a grip on this expansive process and accomplishing this breakthrough.